Cargando…

T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE

Detalles Bibliográficos
Autores principales: Bertani, L., D’Alessandro, C., Fornili, M., Coppini, F., Zanzi, F., Geri, F., Mumolo, M.G., Bellini, M., Baglietto, L., De Bortoli, N., Costa, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065937/
http://dx.doi.org/10.1016/S1590-8658(22)00428-5
_version_ 1784699698352750592
author Bertani, L.
D’Alessandro, C.
Fornili, M.
Coppini, F.
Zanzi, F.
Geri, F.
Mumolo, M.G.
Bellini, M.
Baglietto, L.
De Bortoli, N.
Costa, F.
author_facet Bertani, L.
D’Alessandro, C.
Fornili, M.
Coppini, F.
Zanzi, F.
Geri, F.
Mumolo, M.G.
Bellini, M.
Baglietto, L.
De Bortoli, N.
Costa, F.
author_sort Bertani, L.
collection PubMed
description
format Online
Article
Text
id pubmed-9065937
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-90659372022-05-04 T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE Bertani, L. D’Alessandro, C. Fornili, M. Coppini, F. Zanzi, F. Geri, F. Mumolo, M.G. Bellini, M. Baglietto, L. De Bortoli, N. Costa, F. Dig Liver Dis Poster Presentations Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2022-05 2022-05-04 /pmc/articles/PMC9065937/ http://dx.doi.org/10.1016/S1590-8658(22)00428-5 Text en © 2022 Editrice Gastroenterologica Italiana S.r.l. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Poster Presentations
Bertani, L.
D’Alessandro, C.
Fornili, M.
Coppini, F.
Zanzi, F.
Geri, F.
Mumolo, M.G.
Bellini, M.
Baglietto, L.
De Bortoli, N.
Costa, F.
T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
title T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
title_full T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
title_fullStr T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
title_full_unstemmed T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
title_short T.06.5 ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
title_sort t.06.5 one year of ustekinumab therapy improves nutritional status in patients with crohn’s disease
topic Poster Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065937/
http://dx.doi.org/10.1016/S1590-8658(22)00428-5
work_keys_str_mv AT bertanil t065oneyearofustekinumabtherapyimprovesnutritionalstatusinpatientswithcrohnsdisease
AT dalessandroc t065oneyearofustekinumabtherapyimprovesnutritionalstatusinpatientswithcrohnsdisease
AT fornilim t065oneyearofustekinumabtherapyimprovesnutritionalstatusinpatientswithcrohnsdisease
AT coppinif t065oneyearofustekinumabtherapyimprovesnutritionalstatusinpatientswithcrohnsdisease
AT zanzif t065oneyearofustekinumabtherapyimprovesnutritionalstatusinpatientswithcrohnsdisease
AT gerif t065oneyearofustekinumabtherapyimprovesnutritionalstatusinpatientswithcrohnsdisease
AT mumolomg t065oneyearofustekinumabtherapyimprovesnutritionalstatusinpatientswithcrohnsdisease
AT bellinim t065oneyearofustekinumabtherapyimprovesnutritionalstatusinpatientswithcrohnsdisease
AT bagliettol t065oneyearofustekinumabtherapyimprovesnutritionalstatusinpatientswithcrohnsdisease
AT debortolin t065oneyearofustekinumabtherapyimprovesnutritionalstatusinpatientswithcrohnsdisease
AT costaf t065oneyearofustekinumabtherapyimprovesnutritionalstatusinpatientswithcrohnsdisease